Dr. Magdalena Renne, a leading expert in 3D organoid systems, details how her team has overcome longstanding barriers in ...

Discover the future of Neurofibromatosis Type 1 treatment with our "Pipeline Insight, 2025" report, featuring analysis of 10+ companies and 12+ drugs. Explore the pipeline landscape, drug profiles, ...

A potential target for experimental drugs that block PRMT5—a naturally occurring enzyme some tumors rely more on for survival ...

Diabetes Mellitus is a chronic metabolic disorder and is one of the leading chronic diseases worldwide. It is widely known ...

A potential target for experimental drugs that block PRMT5 - a naturally occurring enzyme some tumors rely more on for ...

Researchers uncover how diabetic peripheral neuropathy weakens bones via disrupted cellular communication using mouse models ...

A potential target for experimental drugs that block PRMT5 — a naturally occurring enzyme some tumors rely more on for survival — has been identified ...

CervoMed Inc. (NASDAQ:CRVO) is one of the best-performing NASDAQ stocks according to analysts. On June 10, CervoMed announced a significant addition to its senior leadership team. Dr.

Sesame seeds and sesame oil are rich in bioactive lignans, tocopherols, and unsaturated fatty acids that exert antioxidant, ...